GAAP Financial Statements
Core Scientific, Inc./tx (CORZZ)
3 quarters · 1 annual periods · CIK 0001839341
Quarterly (3)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2025 | 10-Q | $81.1M | $3.9M | -$57.4M | -$146.7M | $-0.46 | $-0.46 | $2.30B | $453.4M |
| Q2 FY2025 | 10-Q | $62.4M | $1.1M | -$26.3M | -$936.8M | $-0.04 | $-0.04 | $1.98B | $581.3M |
| Q1 FY2025 | 10-Q | $67.2M | $467.0K | -$42.6M | $580.7M | $1.44 | $1.25 | $1.63B | $697.9M |
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2024 | 10-K | $24.4M | $94.4M | -$19.2M | -$1.32B | $-4.39 | $-4.39 | $1.60B | $836.2M |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.